Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)
SEK 3.42
(-2.29%)
SEK 3.42
(-2.29%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.72 SEK | 28.0% |
| 2023 | -1.00 SEK | -33.33% |
| 2022 | -0.75 SEK | -114.29% |
| 2021 | -0.35 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.25 SEK | -38.89% |
| 2024 Q1 | -0.18 SEK | 25.0% |
| 2024 Q4 | 0.07 SEK | 118.36% |
| 2024 Q3 | -0.39 SEK | -56.0% |
| 2023 Q1 | -0.29 SEK | 0.0% |
| 2023 Q2 | -0.25 SEK | 13.79% |
| 2023 FY | - SEK | -33.33% |
| 2023 Q3 | -0.21 SEK | 16.0% |
| 2023 Q4 | -0.24 SEK | -14.29% |
| 2022 FY | - SEK | -114.29% |
| 2021 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AcuCort AB | -0.16 SEK | -350.0% |
| AlzeCure Pharma AB (publ) | -0.60 SEK | -20.0% |
| BioGaia AB (publ) | 3.62 SEK | 119.89% |
| Enzymatica AB (publ) | -0.28 SEK | -157.143% |
| Enorama Pharma AB (publ) | -1.61 SEK | 55.28% |
| Gabather AB (publ) | -0.65 SEK | -10.769% |
| Klaria Pharma Holding AB (publ.) | -0.36 SEK | -100.0% |
| Moberg Pharma AB (publ) | -1.33 SEK | 45.865% |
| Nanexa AB (publ) | -1.09 SEK | 33.945% |
| ODI Pharma AB | 0.02 SEK | 3176.923% |
| Orexo AB (publ) | -3.73 SEK | 80.697% |
| Probi AB (publ) | 1.48 SEK | 148.649% |
| Swedencare AB (publ) | 0.37 SEK | 294.595% |
| Swedish Orphan Biovitrum AB (publ) | 7.47 SEK | 109.639% |
| Toleranzia AB | -0.06 SEK | -1185.714% |
| Vivesto AB | -0.74 SEK | 2.703% |